新医学
新醫學
신의학
NEW CHINESE MEDICINE
2014年
9期
612-616
,共5页
李敏菁%甄国粹%罗志扬%胡少芝
李敏菁%甄國粹%囉誌颺%鬍少芝
리민정%견국수%라지양%호소지
无创正压通气%阻塞性睡眠呼吸暂停低通气综合征%疗效
無創正壓通氣%阻塞性睡眠呼吸暫停低通氣綜閤徵%療效
무창정압통기%조새성수면호흡잠정저통기종합정%료효
Noninvasive positive pressure ventilation%Obstructive sleep apnea hypopnea syndrome%Efficacy
目的:探讨无创正压通气(NPPV)在阻塞性睡眠呼吸暂停低通气综合征(OSAHS)中的应用效果及其对患者远期生活质量的影响。方法选取162例 OSAHS 患者,随机分为治疗组和对照组,每组各81例,两组均予常规治疗,在此基础上治疗组予 NPPV 治疗、对照组则予常规吸氧治疗。一疗程30 d,两组均治疗2个疗程。观察并比较治疗前、后两组患者的临床症状改善情况、多导睡眠监测、血糖、血脂和凝血指标监测结果。治疗后半年随访,比较两组患者的远期生活质量评分。结果治疗后,治疗组 OSAHS 患者除晨起咽痛外的各项临床症状均比治疗前及对照组明显改善(P 均<0.05);其呼吸暂停低通气指数(AHI)均明显下降,平均及最低 SaO2均明显上升,与治疗前及对照组比较差异均有统计意义(P 均<0.01);其血脂、血糖和凝血等指标均比治疗前及对照组明显改善(P 均<0.01)。治疗后半年,对两组患者生活质量进行问卷随访,所有患者均成功随访,无脱落病例。治疗组患者各项生活质量评分均高于对照组(P 均<0.01)。结论NPPV 能明显改善OSAHS 患者的临床症状、控制易引起心脑血管缺血性事件的高危因素(血糖、血脂和血栓形成),提高患者远期生活质量。
目的:探討無創正壓通氣(NPPV)在阻塞性睡眠呼吸暫停低通氣綜閤徵(OSAHS)中的應用效果及其對患者遠期生活質量的影響。方法選取162例 OSAHS 患者,隨機分為治療組和對照組,每組各81例,兩組均予常規治療,在此基礎上治療組予 NPPV 治療、對照組則予常規吸氧治療。一療程30 d,兩組均治療2箇療程。觀察併比較治療前、後兩組患者的臨床癥狀改善情況、多導睡眠鑑測、血糖、血脂和凝血指標鑑測結果。治療後半年隨訪,比較兩組患者的遠期生活質量評分。結果治療後,治療組 OSAHS 患者除晨起嚥痛外的各項臨床癥狀均比治療前及對照組明顯改善(P 均<0.05);其呼吸暫停低通氣指數(AHI)均明顯下降,平均及最低 SaO2均明顯上升,與治療前及對照組比較差異均有統計意義(P 均<0.01);其血脂、血糖和凝血等指標均比治療前及對照組明顯改善(P 均<0.01)。治療後半年,對兩組患者生活質量進行問捲隨訪,所有患者均成功隨訪,無脫落病例。治療組患者各項生活質量評分均高于對照組(P 均<0.01)。結論NPPV 能明顯改善OSAHS 患者的臨床癥狀、控製易引起心腦血管缺血性事件的高危因素(血糖、血脂和血栓形成),提高患者遠期生活質量。
목적:탐토무창정압통기(NPPV)재조새성수면호흡잠정저통기종합정(OSAHS)중적응용효과급기대환자원기생활질량적영향。방법선취162례 OSAHS 환자,수궤분위치료조화대조조,매조각81례,량조균여상규치료,재차기출상치료조여 NPPV 치료、대조조칙여상규흡양치료。일료정30 d,량조균치료2개료정。관찰병비교치료전、후량조환자적림상증상개선정황、다도수면감측、혈당、혈지화응혈지표감측결과。치료후반년수방,비교량조환자적원기생활질량평분。결과치료후,치료조 OSAHS 환자제신기인통외적각항림상증상균비치료전급대조조명현개선(P 균<0.05);기호흡잠정저통기지수(AHI)균명현하강,평균급최저 SaO2균명현상승,여치료전급대조조비교차이균유통계의의(P 균<0.01);기혈지、혈당화응혈등지표균비치료전급대조조명현개선(P 균<0.01)。치료후반년,대량조환자생활질량진행문권수방,소유환자균성공수방,무탈락병례。치료조환자각항생활질량평분균고우대조조(P 균<0.01)。결론NPPV 능명현개선OSAHS 환자적림상증상、공제역인기심뇌혈관결혈성사건적고위인소(혈당、혈지화혈전형성),제고환자원기생활질량。
Objective To investigate the application value of noninvasive positive pressure ventila-tion (NPPV)in treatment of obstructive sleep apnea hypopnea syndrome (OSAHS)and influence upon patients'long-term quality of life.Methods A total of 1 62 OSAHS patients were randomly assigned into the treatment and control groups,81 for each.All subjects received conventional treatment.Patients in the treat-ment group were further treated with NPPV and those in the control group received conventional oxygen inhala-tion.One course of treatment endured for 30 d and two courses of treatment were delivered in both groups.The improvement of clinical symptoms was observed and the outcomes of polysomnography,blood glucose and lipid and coagulation index were compared before and after treatment between both groups.During subsequent 6-month follow-up,the grading of long-term quality of life was compared between two groups.Results Following corresponding treatment,all clinical symptoms except pharyngalgia occurring in the morning in the treatment group were significantly improved compared with those of the control group (all P <0.05).In addition,apnea hypopnea index (AHI)was significantly decreased and mean and minimum SaO2 were significantly increased than pre-treatment values and the control group (all P <0.01 ).The indexes including blood lipid,blood glu-cose and coagulation were equally significantly improved compared with before treatment and the control group (all P <0.01 ).In the 6th months after treatment,all of the patients in two groups completed the question-naires regarding quality of life.All patients were successfully followed up.The grading of each index related to quality of life in the treatment group was significantly higher than that in the control group (all P <0.01 ).Conclusion NPPV could significantly alleviate the clinical symptoms of OSAHS patients,control the high-risk factors potentially inducing cardiocerebral vascular ischemic events (blood glucose,blood lipid and thrombo-sis)and enhance patients'long-term quality of life.